The Graham Number of Keros Therapeutics, Inc. (KROS) is
38.85.
Graham Number estimates the fair value of a stock using both earnings and book value per share. It is commonly used by value investors to identify undervalued stocks.
| Date |
Value |
| 2025-12-31 |
38.85
|
| 2024-12-31 |
23.59
|
| Ticker |
Name |
Value |
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
3.22
|
|
ALEC
|
Alector, Inc.
|
5.88
|
|
KRYS
|
Krystal Biotech, Inc.
|
80.09
|
|
950200.KQ
|
Psomagen Inc
|
1.40
|
|
ANNX
|
Annexon, Inc.
|
21.38
|
|
NKTX
|
Nkarta, Inc.
|
14.40
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
544.10
|
|
STOK
|
Stoke Therapeutics, Inc.
|
9.34
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
160.76
|
|
ZYME
|
Zymeworks Inc.
|
16.78
|
|
AMGN
|
Amgen Inc
|
71.69
|
|
GILD
|
Gilead Sciences, Inc.
|
53.17
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
13.24
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
15.66
|
|
YMAB
|
Y-mAbs Therapeutics Inc
|
10.83
|
|
ABBV
|
AbbVie Inc.
|
10.12
|
|
MRNA
|
Moderna, Inc.
|
157.32
|
|
QURE
|
uniQure N.V.
|
44.74
|